ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606307 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606307; 2) Community: the network communities that were significantly associated with the response to NSC 606307; 3) Molecule: the relationships between components within communities and NSC 606307; 4) MDR: the compounds that were significantly associated with the NSC 606307.

NSC Compound Enrichment Correlation
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0102077332082016 0.3379399
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.0102077332082016 0.16940813
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0102077332082016 0.066998159
NSC 758682 ARTENIMOL 0.0102077332082016 0.35833751
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0102077332082017 0.18620969
NSC 180973 Tamoxifen citrate 0.0102077332082017 0.19315215
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0102077332082017 0.2796467
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 0.0102077332082017 0.36750685
NSC 329691 HM-4 0.0102077332082017 0.080665285
NSC 382046 Null 0.0102077332082017 0.033607549
Total:152  Current:55    [First] [Prev] [Next] [Last]